American Health and Drug Benefits

Scope & Guideline

Pioneering insights into health policy and drug accessibility.

Introduction

Welcome to your portal for understanding American Health and Drug Benefits, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1942-2962
PublisherENGAGE HEALTHCARE COMMUNICATIONS INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2009 to 2023
AbbreviationAM HEALTH DRUG BENEF / Am. Health Drug Benefits
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address318 CLEVELAND AVE, HIGHLAND PARK, NJ 08904

Aims and Scopes

The journal 'American Health and Drug Benefits' focuses on the intersection of healthcare economics, policy, and pharmaceutical benefits, aiming to provide valuable insights into cost-effective treatment strategies and the management of healthcare resources.
  1. Healthcare Economics:
    The journal emphasizes research on the economic aspects of healthcare, including cost-effectiveness analyses and budget impact assessments for medications and treatments.
  2. Drug Utilization and Management:
    It covers studies related to the utilization patterns of drugs, including opioid management and medication therapy management, highlighting strategies to optimize drug use.
  3. Chronic Disease Management:
    The journal frequently publishes articles addressing the management of chronic diseases, including cancer and COPD, focusing on treatment patterns and healthcare costs.
  4. Health Disparities:
    Research on health disparities, particularly in medication adherence and access to care among different racial and ethnic groups, is a critical area of focus.
  5. Policy and Innovation in Healthcare:
    It explores policy implications and innovative approaches in healthcare delivery, particularly regarding the implementation of biosimilars and the impact of Medicare policies.
The journal has seen a shift towards addressing contemporary challenges in healthcare economics and drug management, reflecting emerging trends in the field.
  1. Real-World Evidence in Treatment Patterns:
    There is an increasing emphasis on real-world studies that analyze treatment patterns and healthcare costs, particularly in chronic conditions, which helps inform policy and practice.
  2. Cost-Effectiveness Analyses:
    Recent publications highlight a growing interest in cost-effectiveness studies for various treatments, signaling a trend towards evidence-based economic evaluations in healthcare.
  3. Integration of Biosimilars in Healthcare:
    The implementation strategies for biosimilars are gaining traction, reflecting a broader trend towards innovative treatment options and cost-containment strategies in the pharmaceutical sector.
  4. Addressing Racial and Ethnic Disparities:
    Research focusing on reducing health disparities, especially through Medicare Part D and medication management, is increasingly relevant, highlighting a commitment to equity in healthcare access.
  5. Impact of COVID-19 on Healthcare Practices:
    The effects of the COVID-19 pandemic on medication adherence and healthcare delivery models are emerging themes, indicating a response to the changing landscape of healthcare.

Declining or Waning

While the journal has a strong focus on various aspects of healthcare economics and drug benefits, some themes have shown a decline in prominence over recent years.
  1. Mental Health in Workplace Settings:
    Topics related to mental illness disclosure and workplace improvements have become less frequent, indicating a potential waning interest in this area within the journal's focus.
  2. Historical Perspectives on Healthcare:
    The exploration of historical narratives, such as the 'Government, Big Pharma, and the People' series, appears to be diminishing, suggesting a shift towards more contemporary issues.
  3. General Health Promotion Among College Students:
    Research specifically targeting health promotion and prescription drug misuse among college students seems to be less prevalent, indicating a decrease in focus on this demographic.

Similar Journals

Primary Care Diabetes

Advancing diabetes care through innovative research.
Publisher: ELSEVIER SCI LTDISSN: 1751-9918Frequency: 4 issues/year

Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.

Pharmacy Practice-Granada

Transforming healthcare with cutting-edge pharmaceutical insights.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

JAMA Health Forum

Transforming Knowledge into Action for Health Equity
Publisher: AMER MEDICAL ASSOCISSN: 2689-0186Frequency:

Introducing the JAMA Health Forum, a premier journal published by the American Medical Association, dedicated to advancing knowledge in the critical fields of health policy and public health. Since its inception in 2020, this open-access journal has emerged as a leading platform for high-quality research, achieving a distinguished Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health for 2023. With an ISSN of 2689-0186, it provides a vital resource for researchers, policymakers, and students alike, facilitating widespread dissemination of impactful studies that aim to shape health strategies and improve community health outcomes. The JAMA Health Forum not only fosters collaboration among experts but also enhances global discussions on pressing health issues, making it an essential read for anyone involved in health-related research and practice.

Exploratory Research in Clinical and Social Pharmacy

Fostering collaboration in the evolving pharmacy landscape.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.

Current Oncology

Advancing the Frontiers of Cancer Research
Publisher: MDPIISSN: 1198-0052Frequency: 12 issues/year

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.

Canadian Journal of Kidney Health and Disease

Connecting researchers and practitioners for better patient outcomes.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Connecting professionals to the pulse of health-system pharmacy.
Publisher: OXFORD UNIV PRESS INCISSN: 1079-2082Frequency: 24 issues/year

American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.

International Journal of Clinical Pharmacy

Empowering Healthcare through Innovative Pharmaceutical Research
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

HOSPITAL PHARMACY

Elevating clinical pharmacy standards through scholarly excellence.
Publisher: SAGE PUBLICATIONS INCISSN: 0018-5787Frequency: 6 issues/year

Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.

Healthcare

Fostering collaboration for transformative health advancements.
Publisher: MDPIISSN: Frequency: 12 issues/year

Healthcare is an esteemed academic journal published by MDPI, dedicated to advancing the field of health and medical sciences since its establishment in 2013. Operating from Switzerland, this Open Access journal aims to provide a platform for high-quality research that spans critical disciplines such as Health Informatics, Health Information Management, Health Policy, and Leadership and Management. With a 2023 Impact Factor reflected in its Q3 and Q2 rankings across various categories, Healthcare not only offers visibility and accessibility to innovative research but also fosters collaboration among researchers, professionals, and students dedicated to improving global health outcomes. The journal's commitment to disseminating knowledge and its diverse range of topics make it an essential resource for anyone involved or interested in the continuous evolution of health systems and practices, positioning it as a vital contributor to the future of health research.